Rural Health
Resources by Topic: Pharmacy and prescription drugs
Rural Working-Age Adults Report More Cost Barriers to Health Care
Policy brief examining rural-urban differences in affordability of care and cost-saving strategies among adults ages 18-64. Features demographics and statistics on prescription drug cost-saving measures and difficulty affording medical care in the past year, with breakdowns by rural and urban location.
Author(s): Erika C. Ziller, Carly Milkowski, Amanda Burgess
Date: 03/2023
Sponsoring organization: Maine Rural Health Research Center
view details
Policy brief examining rural-urban differences in affordability of care and cost-saving strategies among adults ages 18-64. Features demographics and statistics on prescription drug cost-saving measures and difficulty affording medical care in the past year, with breakdowns by rural and urban location.
Author(s): Erika C. Ziller, Carly Milkowski, Amanda Burgess
Date: 03/2023
Sponsoring organization: Maine Rural Health Research Center
view details
MedPAC Report to the Congress: Medicare Payment Policy, 2023
Annual review of Medicare payment policies, with recommendations to Congress. Includes discussion on Medicare payment policies directly affecting rural providers and beneficiaries. Addresses payment adequacy for healthcare facilities and services; Medicare Advantage (MA), including a mandated report comparing per enrollee spending in the MA program with that of traditional fee-for-service (FFS) Medicare; and Medicare Part D.
Date: 03/2023
Sponsoring organization: Medicare Payment Advisory Commission
view details
Annual review of Medicare payment policies, with recommendations to Congress. Includes discussion on Medicare payment policies directly affecting rural providers and beneficiaries. Addresses payment adequacy for healthcare facilities and services; Medicare Advantage (MA), including a mandated report comparing per enrollee spending in the MA program with that of traditional fee-for-service (FFS) Medicare; and Medicare Part D.
Date: 03/2023
Sponsoring organization: Medicare Payment Advisory Commission
view details
Report to Congress on Medicaid and CHIP, March 2023
Reports on four aspects of Medicaid: 1) collecting and reporting Medicaid race and ethnicity data, 2) increasing the transparency and improving the collection of nursing facility payment data, 3) strengthening evidence under Medicaid drug coverage, and 4) reviewing hospital payment policy for the nation's safety-net hospitals. Chapter 4 examines the relationship between disproportionate share hospital (DSH) allotments to states and the number of uninsured individuals, the amounts and sources of hospitals' uncompensated care costs, and the number of hospitals with high levels of uncompensated care that also provide essential community services. Table 4-1 details DSH spending for urban and rural hospitals and for Critical Access Hospitals.
Date: 03/2023
Sponsoring organization: Medicaid and CHIP Payment and Access Commission
view details
Reports on four aspects of Medicaid: 1) collecting and reporting Medicaid race and ethnicity data, 2) increasing the transparency and improving the collection of nursing facility payment data, 3) strengthening evidence under Medicaid drug coverage, and 4) reviewing hospital payment policy for the nation's safety-net hospitals. Chapter 4 examines the relationship between disproportionate share hospital (DSH) allotments to states and the number of uninsured individuals, the amounts and sources of hospitals' uncompensated care costs, and the number of hospitals with high levels of uncompensated care that also provide essential community services. Table 4-1 details DSH spending for urban and rural hospitals and for Critical Access Hospitals.
Date: 03/2023
Sponsoring organization: Medicaid and CHIP Payment and Access Commission
view details
Availability of Behavioral Health Providers and Services in Rural Areas, with Holly Andrilla
An episode of the Exploring Rural Health podcast featuring Holly Andrilla, Deputy Director of the WWAMI Rural Health Research Center. Focuses on rural availability of psychiatrists, psychologists, psychiatric nurse practitioners, social workers, and counselors, as well as recent developments in access to medication for opioid use disorder (MOUD).
Date: 03/2023
Sponsoring organization: Rural Health Information Hub
view details
An episode of the Exploring Rural Health podcast featuring Holly Andrilla, Deputy Director of the WWAMI Rural Health Research Center. Focuses on rural availability of psychiatrists, psychologists, psychiatric nurse practitioners, social workers, and counselors, as well as recent developments in access to medication for opioid use disorder (MOUD).
Date: 03/2023
Sponsoring organization: Rural Health Information Hub
view details
The Approaching End of the COVID-19 Public Health Emergency and Its Implications for RHCs
Outlines Rural Health Clinic (RHC)-specific waivers implemented in response to the COVID-19 pandemic and will end at the conclusion of the public health emergency (PHE). Highlights how other policies will be impacted by the end of the PHE, including telehealth flexibilities; Medicaid redetermination; the commercialization of COVID-19 vaccines, treatments, and tests; and Emergency Use Authorizations.
Date: 02/2023
Sponsoring organization: National Association of Rural Health Clinics
view details
Outlines Rural Health Clinic (RHC)-specific waivers implemented in response to the COVID-19 pandemic and will end at the conclusion of the public health emergency (PHE). Highlights how other policies will be impacted by the end of the PHE, including telehealth flexibilities; Medicaid redetermination; the commercialization of COVID-19 vaccines, treatments, and tests; and Emergency Use Authorizations.
Date: 02/2023
Sponsoring organization: National Association of Rural Health Clinics
view details
COVID-19 Booster Vaccination in Rural Community Pharmacies
Examines perceptions surrounding COVID-19 booster vaccinations in rural southeastern community pharmacies. Utilizes February-March 2022 survey data from 112 pharmacists part of the the Rural Research Alliance of Community Pharmacies (RURAL-CP) and analyzes number of pharmacies offering COVID-19 booster vaccinations, reasons for choosing versus not choosing vaccination, barriers to COVID-19 booster vaccinations, and more.
Author(s): Abigail Gamble, Tessa J. Hastings, Salisa C. Westrick, et al.
Citation: Vaccine, 41(5), 999-1002
Date: 01/2023
view details
Examines perceptions surrounding COVID-19 booster vaccinations in rural southeastern community pharmacies. Utilizes February-March 2022 survey data from 112 pharmacists part of the the Rural Research Alliance of Community Pharmacies (RURAL-CP) and analyzes number of pharmacies offering COVID-19 booster vaccinations, reasons for choosing versus not choosing vaccination, barriers to COVID-19 booster vaccinations, and more.
Author(s): Abigail Gamble, Tessa J. Hastings, Salisa C. Westrick, et al.
Citation: Vaccine, 41(5), 999-1002
Date: 01/2023
view details
Rural Americans' COVID-19 Vaccine Perceptions and Willingness to Vaccinate against COVID-19 with Their Community Pharmacists: An Exploratory Study
Presents a study on the perceptions of rural people on the COVID-19 vaccine and their willingness to receive a vaccine from their community pharmacist. Bases findings on phone-based interviews with rural adults. Breaks down data by age, sex, and education, among other measures.
Author(s): Alexis M. Koskan, Iris E. LoCoco, Casey L. Daniel, et al.
Citation: Vaccines, 11(1), 171
Date: 01/2023
view details
Presents a study on the perceptions of rural people on the COVID-19 vaccine and their willingness to receive a vaccine from their community pharmacist. Bases findings on phone-based interviews with rural adults. Breaks down data by age, sex, and education, among other measures.
Author(s): Alexis M. Koskan, Iris E. LoCoco, Casey L. Daniel, et al.
Citation: Vaccines, 11(1), 171
Date: 01/2023
view details
Challenges with Vaccination Data Hinder State and Local Immunization Program Efforts to Combat COVID-19
Presents results of a December 2021 survey of 56 state and local immunization programs regarding whether they receive individual-level COVID-19 vaccination data from Federal agencies and retail pharmacy partners. Discusses the impact of having incomplete individual-level vaccination data on reaching unvaccinated and vulnerable populations, including rural populations and American Indians and Alaska Natives (AI/ANs). Includes recommendations for the CDC to mitigate data gaps and ensure that state and local immunization programs are aware of existing tools to address vaccination campaign needs.
Date: 01/2023
Sponsoring organization: Office of Inspector General (HHS)
view details
Presents results of a December 2021 survey of 56 state and local immunization programs regarding whether they receive individual-level COVID-19 vaccination data from Federal agencies and retail pharmacy partners. Discusses the impact of having incomplete individual-level vaccination data on reaching unvaccinated and vulnerable populations, including rural populations and American Indians and Alaska Natives (AI/ANs). Includes recommendations for the CDC to mitigate data gaps and ensure that state and local immunization programs are aware of existing tools to address vaccination campaign needs.
Date: 01/2023
Sponsoring organization: Office of Inspector General (HHS)
view details
Telemedicine Use and Quality of Opioid Use Disorder Treatment in the US During the COVID-19 Pandemic
Results of a study of 1,768 clinicians treating 11,801 patients with opioid use disorder (OUD), to examine the association between telemedicine adoption during the COVID-19 pandemic and indicators of OUD treatment quality. Explores medications for OUD (MOUD) prescribing and OUD-related clinical events, including drug overdose, inpatient detoxification, and rehabilitation center stay. Features statistics including patient and clinician characteristics, with breakdowns by metropolitan, micropolitan, small town, and rural location.
Author(s): Ruth Hailu, Ateev Mehrotra, Haiden A. Huskamp, Alisa B. Busch, Michael L. Barnett
Citation: JAMA Network Open, 6(1)
Date: 01/2023
view details
Results of a study of 1,768 clinicians treating 11,801 patients with opioid use disorder (OUD), to examine the association between telemedicine adoption during the COVID-19 pandemic and indicators of OUD treatment quality. Explores medications for OUD (MOUD) prescribing and OUD-related clinical events, including drug overdose, inpatient detoxification, and rehabilitation center stay. Features statistics including patient and clinician characteristics, with breakdowns by metropolitan, micropolitan, small town, and rural location.
Author(s): Ruth Hailu, Ateev Mehrotra, Haiden A. Huskamp, Alisa B. Busch, Michael L. Barnett
Citation: JAMA Network Open, 6(1)
Date: 01/2023
view details
Travel Times to Facilities Offering Oral Medication Therapy for COVID-19
Results of a study exploring accessibility of oral COVID-19 therapeutics across the United States, by examining travel times to places where these medications are available. Features a county-level map with shadings showing ranges of travel time by census tract.
Author(s): Peter A. Kahn, Xiaohan Ying, Walter S. Mathis
Citation: JAMA Network Open, 6(1)
Date: 01/2023
view details
Results of a study exploring accessibility of oral COVID-19 therapeutics across the United States, by examining travel times to places where these medications are available. Features a county-level map with shadings showing ranges of travel time by census tract.
Author(s): Peter A. Kahn, Xiaohan Ying, Walter S. Mathis
Citation: JAMA Network Open, 6(1)
Date: 01/2023
view details